PATENT CLAIM ANALYSIS

Application Number: 16230412
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["514", "250000"]

Abstract:
This invention is in the area of pyrimidine-based compounds for the treatment of disorders involving abnormal cellular proliferation, including but not limited to tumors and cancers.

Claim (Index 9):
The compound of  claim 8 , wherein R x  at each occurrence is independently selected from halo, cyano, nitro, oxo, alkyl, haloalkyl, alkenyl, alkynyl, cycloalkyl, heterocyclo, aryl, heteroaryl, arylalkyl, heteroarylalkyl, cycloalkylalkyl, and heterocycloalkyl.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 98.0
- Lexical Diversity: 1.07692
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['16230388', '14690180', '15419642', '15288878', '12567258']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7959936806098385
- 35 USC 102 Novelty (BERT): 0.6003008700687631
- Combined Prediction Score: 0.776424399555731
- Mean Citation Score: 399.841996
- Max Citation Score: 488.13474
- Similarity Product: 480.01976808792114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test